Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Placebo Controlled, Randomized, Double Blind, Subject Initiated Study of the Safety and Efficacy of the Electrokinetic Transdermal System (ETS) With Acyclovir Gel for the Episodic Treatment of Herpes Labialis

NCT00469300 is registered in ClinicalTrials.gov with Transport Pharmaceuticals as lead sponsor.

NCT NCT00469300
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00469300 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Placebo Controlled, Randomized, Double Blind, Subject Initiated Study of the Safety and Efficacy of the Electrokinetic Transdermal System (ETS) With Acyclovir Gel for the Episodic Treatment of Herpes Labialis
Lead sponsor
Transport Pharmaceuticals
Phase
Phase 2
Overall status
Completed
Start date
April 30, 2007
Completion date
October 31, 2007
Enrollment
810 (estimated)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

herpes labialis